Literature DB >> 19032611

Glycodelin A induces a tolerogenic phenotype in monocyte-derived dendritic cells in vitro.

Christoph Scholz1, Bettina Toth, Regina Brunnhuber, Elisabeth Rampf, Tobias Weissenbacher, Laura Santoso, Klaus Friese, Udo Jeschke.   

Abstract

PROBLEM: Successful mammalian pregnancy requires a delicate immunological balance at the feto-maternal interface that allows the semi-allogeneic fetus to grow, while protecting mother and child from environmental pathogens. As in other mucosal tissues, antigen-recognition and -handling by professional antigen-presenting cells such as dendritic cells (DC) determine the course of the subsequent immune response. DC at the feto-maternal interface help shape this immunological equilibrium. Endometrial tissue secretes high quantities of glycodelin A (GdA) during the so-called fertile window (i.e. the time of implantation of the blastocyst). METHOD OF STUDY: We investigated the effect of GdA on monocyte-derived DC (moDC) regarding surface marker expression, endopinocytotic activity, cytokine profile as well as lymphoproliferative activity.
RESULTS: Upon pretreatment with GdA and subsequent maturation with tumor necrosis factor-alpha and interleukin (IL)-1beta, moDC displayed a reduced expression of costimulatory molecules, an unchanged major histocompatibility complex-II expression and persistence of DC-SIGN positive cells. GdA-pretreated moDC had a higher endopinocytotic activity, an increased IL-10 production and a dose-dependent reduction in lymphoproliferative activity. GdA incubation alone did not alter the immature phenotype.
CONCLUSION: Our results suggest a model in which the human endometrium secretes high quantities of GdA during implantation and thereby helps to shape the unique immunological interaction between mother and fetus via decidual DC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032611     DOI: 10.1111/j.1600-0897.2008.00647.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  14 in total

1.  Immunomodulatory activity of glycodelin: implications in allograft rejection.

Authors:  A Dixit; B Balakrishnan; A A Karande
Journal:  Clin Exp Immunol       Date:  2018-01-18       Impact factor: 4.330

Review 2.  Contraceptive vaccines targeting factors involved in establishment of pregnancy.

Authors:  Angela R Lemons; Rajesh K Naz
Journal:  Am J Reprod Immunol       Date:  2011-04-11       Impact factor: 3.886

Review 3.  Role and therapeutic potential of Glycodelin A in systemic lupus erythematosus.

Authors:  Hai-Feng Pan; Rui-Xue Leng; Ning Zhang; Jin-Hui Tao; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2010-12-03       Impact factor: 2.631

4.  Glycodelin-A stimulates interleukin-6 secretion by human monocytes and macrophages through L-selectin and the extracellular signal-regulated kinase pathway.

Authors:  Cheuk-Lun Lee; Eve Y F Lam; Kevin K W Lam; Hannu Koistinen; Markku Seppälä; Ernest H Y Ng; William S B Yeung; Philip C N Chiu
Journal:  J Biol Chem       Date:  2012-09-12       Impact factor: 5.157

5.  Identification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.

Authors:  Jun Liang; Jing Lv; Zimin Liu
Journal:  Tumour Biol       Date:  2015-04-11

Review 6.  Inflammation and pregnancy: the role of the immune system at the implantation site.

Authors:  Gil Mor; Ingrid Cardenas; Vikki Abrahams; Seth Guller
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

Review 7.  Inflammation and implantation.

Authors:  Nava Dekel; Yulia Gnainsky; Irit Granot; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2010-01       Impact factor: 3.886

Review 8.  The role of inflammation for a successful implantation.

Authors:  Nava Dekel; Yulia Gnainsky; Irit Granot; Karen Racicot; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2014-05-09       Impact factor: 3.886

Review 9.  The immunomodulating roles of glycoproteins in epithelial ovarian cancer.

Authors:  Manish S Patankar; Jennifer A A Gubbels; Mildred Felder; Joseph P Connor
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

10.  Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.

Authors:  Christoph Scholz; Sabine Heublein; Miriam Lenhard; Klaus Friese; Doris Mayr; Udo Jeschke
Journal:  BMC Res Notes       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.